photoThis company has introduced three Therapeutic Drug Monitoring (TDM) and Drugs of Abuse (DAT) reagents.
     In ready-to-use formulations, the new TDMs are Phenytoin, Phenobarbital, N-acetylprocainamide, Digoxin and Quinidine, and the DATs are Benzodiazepine, Opiate, Cannabinoids. They feature 60-to-90-day on-board stability with 14-day calibration stability on this company’s full line of automated chemistry-immuno analyzers, including the AU400, AU600, AU640 and AU2700 systems.
     The reagents are barcoded for greater operator convenience and better on-board reagent management.
     The full line of Emit 2000 TDM reagents and Emit II Plus DAT reagents are expected to be available in this company’s barcoded packaging later this year. Emit 1.0 TDM reagents will continue to be distributed in existing Syva packaging.
Olympus America
Keyword: reagent, TDM, DAT